Edoc 收购公司（纳斯达克股票代码：ADOC）空头利率更新

Edoc Acquisition Corp. (NASDAQ:ADOC – Get Rating) was the recipient of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 8,800 shares, a decline of 9.3% from the February 13th total of 9,700 shares. Currently, 0.4% of the company's shares are sold short. Based on an average trading volume of 10,300 shares, the short-interest ratio is currently 0.9 days.

Edoc Acquisition Price Performance

NASDAQ:ADOC opened at $10.72 on Wednesday. Edoc Acquisition has a 1 year low of $10.12 and a 1 year high of $10.99. The stock has a 50-day moving average price of $10.66 and a two-hundred day moving average price of $10.46.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ADOC. Glazer Capital LLC acquired a new position in Edoc Acquisition in the fourth quarter valued at about $1,864,000. Cubist Systematic Strategies LLC acquired a new position in Edoc Acquisition in the third quarter valued at about $977,000. Logan Stone Capital LLC acquired a new position in Edoc Acquisition in the third quarter valued at about $737,000. Sea Otter Advisors LLC acquired a new position in Edoc Acquisition in the fourth quarter valued at about $364,000. Finally, Clear Street LLC grew its stake in Edoc Acquisition by 2,598.4% in the fourth quarter. Clear Street LLC now owns 27,632 shares of the company's stock valued at $290,000 after acquiring an additional 26,608 shares during the period. 35.14% of the stock is owned by institutional investors and hedge funds.

About Edoc Acquisition

(Get Rating)

Edoc Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the health care and health care provider space in North America and the Asia-Pacific.

Featured Articles

• Get a free copy of the StockNews.com research report on Edoc Acquisition (ADOC)
• Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
• GitLab Crashes On Guidance; Analysts Defend
• Healthcare Stocks With at Least 30 Years of Dividend Increases
• Coinbase Pops As SVB Crumbles To Dust
• Airlines Update Guidance, Shares Head For Different Destinations

Receive News & Ratings for Edoc Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edoc Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.